March 14th

 SECTION 3: Alterations beyond mutations: Epigenetics / Fusions and rearrangements 

​​

 08h30-08h50  

Basic concepts of methylome

Felipe Andreiuolo

​​

 08h50-09h10 

Epigenetics and cancer- Applications in diagnostic pathology

Martha Quezado (NIH)
 

 09h10-09h30  

Analytical aspects of testing for rearrangements and fusions

Paulo Vidal Campregher

​

 09h30-10h00 

Discussion
 

 10h00 - 10h30 

Corporate Workshop Astrazeneca
HER2 score in breast cancer: recognition low and ultralow cases and evaluation of the use of artificial intelligence.

Fernando Soares

 10h30-11h00 

Coffe-break
 

 SECTION 4: Liquid Biopsy - evidences for use in clinical practice 

​​

 11h00-11h20 

Role of Liquid Biopsy for biomarker testing

Valeria Denninghoff

​

 11h20-11h40 

Monitoring and early stage disease

Federico Monzon
 

 11h40-12h00 

Other sources of cfDNA for biomarker testing

Maria Arcila
 

 12h00-12h30 

Discussion
 

 12h30 - 14h00 

Break
 

 SECTION 5: Tumor Signatures – applications and challenges on implementation 

​​

 14h00-14h30 

Molecular signatures and Homologous recombination repair - how to use in diagnostics

Larissa Furtado
 

 14h30-15h00 

Tumor Mutational Burden and Microsatellite instability

Larissa Furtado
 

 15h15-15h30 

Discussion

 

 15h30 - 16h00 

Coffee Break

​

 SECTION 6: Future perspectives 

​​

 16h00-16h20 

Spatial pathomics

Edwin Parra
 

 16h20-16h40 

Artificial intelligence in Molecular Pathology – Increasing roles and applications 

Larissa Furtado
 

 16h40-17h00 

Discussion
 

 17h00-18h00 

Implementing molecular diagnostics Latin American Perspectives

Moderator: 
Isabela Werneck

Pannelists:

Giovana Tardin Torrezan

Carla Daniele de Godoy  

Cristóvão Scapulatempo

Francine Oliveira

Iberê Soares 

Juliana Cordeiro

Leonard Silva

Mariana Petaccia de Macedo

Paulo Campregher

Roberta Sitnik
Sergio Sánchez Sosa

​

 18h00 

Closing Remarks

Maria Arcila